Directory
>
Mark Rowen
Mark Rowen
Research Chemist | Denali Therapeutics
California, San Francisco, United States
Mark Rowen
Summary
Mark Rowen is a seasoned leader in corporate development with over 19 years of experience in the biotech and pharmaceutical industries. Currently serving as Vice President of Corporate Development at Denali Therapeutics, he excels in establishing and managing strategic partnerships that drive the discovery and development of innovative medicines. His extensive background includes negotiating complex agreements and leading cross-functional teams in high-stakes environments. Mark's educational foundation in Chemistry and Business, coupled with a finance degree from the Wharton School, equips him with a unique blend of scientific and business acumen. He is passionate about leveraging technology and collaboration to enhance drug discovery processes. Outside of his corporate role, Mark is known for his commitment to mentoring emerging leaders in the industry. His ability to navigate the complexities of alliances and governance makes him a valuable asset in the healthcare sector.
Mark Rowen
Work Experience
Vice President Corporate Development at
Denali Therapeutics
October 2022 - Present
Mark Rowen
Education
University of Guelph, Bachelor's Degree, Chemistry and Business
January 1992 - January 1997
Wharton School, Finance
January 2009 - January 2009
Frequently Asked Questions about Mark Rowen
What is Mark Rowen email address?
Mark Rowen's primary email address is *****@denalitherapeutics.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Mark Rowen work for?
Mark Rowen is a Research Chemist at Denali Therapeutics.
Where Mark Rowen graduated from?
Mark Rowen holds a degree in null from University of Guelph.
How can I directly contact Mark Rowen?
To contact Mark Rowen directly, you can use the email address *****@denalitherapeutics.com. Complete contact information is available upon registration with Muraena.
Who is Mark Rowen?
Mark Rowen is a seasoned leader in corporate development with over 19 years of experience in the biotech and pharmaceutical industries. Currently serving as Vice President of Corporate Development at Denali Therapeutics, he excels in establishing and managing strategic partnerships that drive the discovery and development of innovative medicines. His extensive background includes negotiating complex agreements and leading cross-functional teams in high-stakes environments. Mark's educational foundation in Chemistry and Business, coupled with a finance degree from the Wharton School, equips him with a unique blend of scientific and business acumen. He is passionate about leveraging technology and collaboration to enhance drug discovery processes. Outside of his corporate role, Mark is known for his commitment to mentoring emerging leaders in the industry. His ability to navigate the complexities of alliances and governance makes him a valuable asset in the healthcare sector.
Mark`s contact details
*****@denalitherapeutics.com
******@gene.com
Colleagues
Movement Disorders Fellow
Staff Research Associate II
Research Associate
Sr. Associate Scientist
Technical Operations Process Engineer
Postdoctoral Fellow
Investment Banking Associate
Assistant Manager
Senior Director, Corporate Development
Marine, Staff Sergeant